BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8628088)

  • 1. Human nasal epithelium adsorbs complement C3-related fragments and expresses cell membrane complement regulatory proteins.
    Varsano S; Frolkis I; Shapiro H; Ophir D
    Laryngoscope; 1996 May; 106(5 Pt 1):599-604. PubMed ID: 8628088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
    Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
    Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
    Varsano S; Frolkis I; Rashkovsky L; Ophir D; Fishelson Z
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):731-7. PubMed ID: 8969267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
    Iborra A; Mayorga M; Llobet N; Martínez P
    Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of membrane inhibitors of complement in human gastric epithelium during Helicobacter-associated gastritis.
    Sasaki M; Joh T; Tada T; Okada N; Yokoyama Y; Itoh M
    Histopathology; 1998 Dec; 33(6):554-60. PubMed ID: 9870151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of ovarian teratocarcinoma cell spheroids to complement-mediated lysis.
    Bjørge L; Junnikkala S; Kristoffersen EK; Hakulinen J; Matre R; Meri S
    Br J Cancer; 1997; 75(9):1247-55. PubMed ID: 9155042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
    Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
    Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
    Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion.
    Närkiö-Mäkelä M; Jero J; Meri S
    Clin Exp Immunol; 1999 Jun; 116(3):401-9. PubMed ID: 10361226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract.
    Varsano S; Frolkis I; Ophir D
    Am J Respir Crit Care Med; 1995 Sep; 152(3):1087-93. PubMed ID: 7545058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line.
    Varsano S; Kaminsky M; Kaiser M; Rashkovsky L
    Thorax; 2000 May; 55(5):364-9. PubMed ID: 10770816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells.
    Cosio FG; Shibata T; Rovin BH; Birmingham DJ
    Kidney Int; 1994 Oct; 46(4):986-92. PubMed ID: 7532249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques.
    Yasojima K; Schwab C; McGeer EG; McGeer PL
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1214-9. PubMed ID: 11451754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
    Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
    Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues.
    Thorsteinsson L; O'Dowd GM; Harrington PM; Johnson PM
    APMIS; 1998 Sep; 106(9):869-78. PubMed ID: 9808413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis.
    Simpson KL; Holmes CH
    Immunology; 1994 Mar; 81(3):452-61. PubMed ID: 7515850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of complement regulatory proteins on human eggs and preimplantation embryos.
    Fenichel P; Donzeau M; Cervoni F; Menezo Y; Hsi BL
    Am J Reprod Immunol; 1995 Feb; 33(2):155-64. PubMed ID: 7544131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation.
    van Beek J; van Meurs M; 't Hart BA; Brok HP; Neal JW; Chatagner A; Harris CL; Omidvar N; Morgan BP; Laman JD; Gasque P
    J Immunol; 2005 Feb; 174(4):2353-65. PubMed ID: 15699172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma.
    Gelderman KA; Kuppen PJ; Bruin W; Fleuren GJ; Gorter A
    Eur J Immunol; 2002 Jan; 32(1):128-35. PubMed ID: 11754353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.